JPWO2024014524A5 - - Google Patents
Info
- Publication number
- JPWO2024014524A5 JPWO2024014524A5 JP2024533757A JP2024533757A JPWO2024014524A5 JP WO2024014524 A5 JPWO2024014524 A5 JP WO2024014524A5 JP 2024533757 A JP2024533757 A JP 2024533757A JP 2024533757 A JP2024533757 A JP 2024533757A JP WO2024014524 A5 JPWO2024014524 A5 JP WO2024014524A5
- Authority
- JP
- Japan
- Prior art keywords
- patients
- administration
- statin
- ldl cholesterol
- methoxyphenoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022113930 | 2022-07-15 | ||
| PCT/JP2023/025980 WO2024014524A1 (ja) | 2022-07-15 | 2023-07-14 | 血中ldlコレステロール低下剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2024014524A1 JPWO2024014524A1 (cg-RX-API-DMAC7.html) | 2024-01-18 |
| JPWO2024014524A5 true JPWO2024014524A5 (cg-RX-API-DMAC7.html) | 2026-06-23 |
Family
ID=89536850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533757A Pending JPWO2024014524A1 (cg-RX-API-DMAC7.html) | 2022-07-15 | 2023-07-14 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20260014122A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4556006A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2024014524A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250034041A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119546300A (cg-RX-API-DMAC7.html) |
| JO (1) | JOP20250007A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202408500A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024014524A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20110009T1 (hr) | 2003-09-03 | 2011-03-31 | Kowa Co. | Spoj kojim se aktivira ppar i farmaceutski pripravak koji ga sadrži |
| TWI696462B (zh) * | 2013-07-10 | 2020-06-21 | 日商興和股份有限公司 | 非酒精性脂肪性肝疾病治療劑 |
| PT3275438T (pt) * | 2016-07-29 | 2021-01-25 | Kowa Co | Métodos de prevenção de eventos cardiovasculares em populações dislipidémicas de risco residual |
| US11446282B2 (en) * | 2017-12-21 | 2022-09-20 | Kowa Company, Ltd. | Methods of treating mixed dyslipidemia and hypertriglycertdemia |
| CA3085951C (en) * | 2017-12-21 | 2022-10-11 | Kowa Company, Ltd. | Methods of treatment of hypertriglyceridemia |
| EP4346809B1 (en) * | 2021-05-27 | 2026-07-15 | Kowa Company, Ltd. | Pemafibrate for use in treating liver disease |
-
2023
- 2023-07-14 JP JP2024533757A patent/JPWO2024014524A1/ja active Pending
- 2023-07-14 US US18/880,136 patent/US20260014122A1/en active Pending
- 2023-07-14 WO PCT/JP2023/025980 patent/WO2024014524A1/ja not_active Ceased
- 2023-07-14 TW TW112126331A patent/TW202408500A/zh unknown
- 2023-07-14 CN CN202380054016.8A patent/CN119546300A/zh active Pending
- 2023-07-14 EP EP23839693.1A patent/EP4556006A4/en active Pending
- 2023-07-14 KR KR1020247043248A patent/KR20250034041A/ko active Pending
-
2025
- 2025-01-13 JO JOJO/P/2025/0007A patent/JOP20250007A1/ar unknown